Answers are grounded in this paper and cite their sources.
Introduction: In hepatocellular cancer (HCC), reduced muscle mass and quality are associated with worse overall survival, higher risk of tumor recurrence, and lower objective response rate. However, the underlying biological mechanisms remain unclear. This exploratory, retrospective single-center study aimed to describe associations between CT-derived body composition and intratumoral CD45+ leukocyte density (CD45, the leukocyte common antigen) in patients with HCC. Methods: The sample comprised 53 treatment-naive patients. Body composition was measured semiautomatically with ImageJ on a single axial slice at the third lumbar vertebra from staging computed tomography (CT). The total tumor cell count and the mean number of intratumoral CD45-positive leukocytes were estimated in biopsy specimens. The proportion of CD45+ leukocytes (CD45+ leukocytes divided by the total cell count, expressed as a percentage) was calculated. Data were summarized with descriptive statistics. Results: Low skeletal muscle mass was diagnosed in 32 patients (60%), high visceral adipose tissue in 26 patients (49%), myosteatosis in 18 patients (34%), and high subcutaneous adipose tissue in 26 patients (49%). The median proportion of intratumoral CD45+ leukocytes was 2.7% (IQR 1.4–8.4). Patients with myosteatosis had a lower proportion of CD45+ leukocytes than those with normal muscle density (median 1.9% [IQR 0.5–4.5] vs 3.9% [2.1–10.0], p=0.026). Other parameters of body composition showed no associations with CD45+ leukocytes. Conclusion: In this exploratory analysis, myosteatosis was associated with lower intratumoral CD45+ leukocyte density in HCC. Because CD45 is nonspecific and the sample was small and unadjusted, this hypothesis-generating finding requires confirmation in larger, adjusted studies.
No takes yet. Share an insight, caveat, or question.
Surov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: